Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma. - Machiels JP; Tao Y; Licitra L; Burtness B; Tahara M; Rischin D; Alves GV; Lima IPF; Hughes BGM; Pointreau Y; Aksoy S; Laban S; et al. (Frontiers in oncology, 2025)